胰腺癌的辅助治疗

对于胰腺癌术后状态,研究表明进行吉西他滨全身化疗能够显著提高无瘤生存期和总生存期,而辅助放化疗则存在较大争议;局部介入化疗在小样本的研究中获得肯定,但仍缺乏大样本随机对照研究予以证实;新辅助治疗对于评价为可能切除的胰腺癌病灶提供了外科切除的可能.

Adjuvant therapy for pancreatic cancer

For having resected pancreatic cancer patients, study shows that chemotherapy by gemcitabine can significantly improve disease-free survival and overall survival, while adjuvant chemoradiotherapy has great controversy; The local interventional chemotherapy is apprved in some studies with small sample, but still lacks of large sample randomized controlled study to confirm. The neoadjuvant therapy, for having evaluated as possible resection of pancreatic cancer, provides the possibility of surgical resection, it has great significance to improve the overall survival.